Maximising the public health benefit of antimalarials

Research output: Contribution to journalComment/debateResearch

Abstract

[No abstract available]
Original languageEnglish
Pages (from-to)654-655
Number of pages2
JournalLancet Infectious Diseases
Volume10
Issue number10
DOIs
Publication statusPublished - 1 Oct 2010

Keywords

  • Antimalarials
  • Artemisinins
  • Drug Therapy, Combination
  • Humans
  • Lactones
  • Malaria
  • Plasmodium
  • Plasmodium falciparum
  • Plasmodium vivax
  • Plasmodium vivax malaria
  • amodiaquine plus artesunate
  • antimalarial activity
  • antimalarial agent
  • antimalarial drug resistance
  • artemether plus benflumetol
  • artemisin
  • artemisinin derivative
  • artesunate
  • artesunate plus mefloquine
  • clinical trial
  • dihydroartemisinin plus piperaquine
  • disease transmission
  • drug combination
  • drug effects
  • drug efficacy
  • gametocyte
  • glucose 6 phosphate dehydrogenase deficiency
  • hemolysis
  • human
  • lactone
  • letter
  • malaria
  • malaria falciparum
  • mefloquine
  • mixed infection
  • parasite control
  • piperaquine
  • primaquine
  • priority journal
  • procedures
  • single drug dose

Fingerprint Dive into the research topics of 'Maximising the public health benefit of antimalarials'. Together they form a unique fingerprint.

Cite this